vs
Side-by-side financial comparison of RBC Bearings INC (RBC) and Bio-Techne (TECH). Click either name above to swap in a different company.
RBC Bearings INC is the larger business by last-quarter revenue ($461.6M vs $295.9M, roughly 1.6× Bio-Techne). RBC Bearings INC runs the higher net margin — 14.6% vs 12.8%, a 1.8% gap on every dollar of revenue. On growth, RBC Bearings INC posted the faster year-over-year revenue change (17.0% vs -6.4%). Over the past eight quarters, RBC Bearings INC's revenue compounded faster (5.6% CAGR vs 4.2%).
Dover Corporation is an American conglomerate manufacturer of industrial products. The Downers Grove, Illinois-based company was founded in 1955. As of 2021, Dover's business was divided into five segments: Engineered Products, Clean Energy and Fueling, Imaging & Identification, Pumps & Process Solutions and Climate and Sustainability Technologies. Dover is a constituent of the S&P 500 index and trades on the New York Stock Exchange under the symbol DOV. Dover was ranked 448 in the 2024 Fortu...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
RBC vs TECH — Head-to-Head
Income Statement — Q3 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $461.6M | $295.9M |
| Net Profit | $67.4M | $38.0M |
| Gross Margin | 44.3% | 64.6% |
| Operating Margin | 22.3% | 18.4% |
| Net Margin | 14.6% | 12.8% |
| Revenue YoY | 17.0% | -6.4% |
| Net Profit YoY | 16.4% | 68.3% |
| EPS (diluted) | $2.13 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $461.6M | $295.9M | ||
| Q3 25 | $455.3M | — | ||
| Q2 25 | $436.0M | $317.0M | ||
| Q1 25 | $437.7M | $316.2M | ||
| Q4 24 | $394.4M | $297.0M | ||
| Q3 24 | $397.9M | $289.5M | ||
| Q2 24 | $406.3M | $306.1M | ||
| Q1 24 | $413.7M | $303.4M |
| Q4 25 | $67.4M | $38.0M | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $68.5M | $-17.7M | ||
| Q1 25 | $72.7M | $22.6M | ||
| Q4 24 | $57.9M | $34.9M | ||
| Q3 24 | $54.2M | $33.6M | ||
| Q2 24 | $61.4M | $40.6M | ||
| Q1 24 | — | $49.1M |
| Q4 25 | 44.3% | 64.6% | ||
| Q3 25 | 44.1% | — | ||
| Q2 25 | 44.8% | 62.7% | ||
| Q1 25 | 44.2% | 67.9% | ||
| Q4 24 | 44.3% | 65.3% | ||
| Q3 24 | 43.7% | 63.2% | ||
| Q2 24 | 45.3% | 66.4% | ||
| Q1 24 | 43.1% | 67.4% |
| Q4 25 | 22.3% | 18.4% | ||
| Q3 25 | 21.5% | — | ||
| Q2 25 | 23.2% | -7.5% | ||
| Q1 25 | 23.0% | 12.2% | ||
| Q4 24 | 21.7% | 16.0% | ||
| Q3 24 | 21.6% | 13.8% | ||
| Q2 24 | 24.0% | 15.0% | ||
| Q1 24 | 22.8% | 22.1% |
| Q4 25 | 14.6% | 12.8% | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | 15.7% | -5.6% | ||
| Q1 25 | 16.6% | 7.1% | ||
| Q4 24 | 14.7% | 11.7% | ||
| Q3 24 | 13.6% | 11.6% | ||
| Q2 24 | 15.1% | 13.3% | ||
| Q1 24 | — | 16.2% |
| Q4 25 | $2.13 | $0.24 | ||
| Q3 25 | $1.90 | — | ||
| Q2 25 | $2.17 | $-0.11 | ||
| Q1 25 | $2.33 | $0.14 | ||
| Q4 24 | $1.82 | $0.22 | ||
| Q3 24 | $1.65 | $0.21 | ||
| Q2 24 | $1.90 | $0.26 | ||
| Q1 24 | $1.92 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $107.6M | $172.9M |
| Total DebtLower is stronger | $990.2M | $260.0M |
| Stockholders' EquityBook value | $3.3B | $2.0B |
| Total Assets | $5.1B | $2.5B |
| Debt / EquityLower = less leverage | 0.30× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $107.6M | $172.9M | ||
| Q3 25 | $91.2M | — | ||
| Q2 25 | $132.9M | $162.2M | ||
| Q1 25 | $36.8M | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | $76.8M | $152.9M | ||
| Q1 24 | $63.5M | $145.3M |
| Q4 25 | $990.2M | $260.0M | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $915.6M | $346.0M | ||
| Q1 25 | $920.1M | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | $1.2B | $389.0M |
| Q4 25 | $3.3B | $2.0B | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $2.9B | $2.1B | ||
| Q3 24 | $2.9B | $2.1B | ||
| Q2 24 | $2.8B | $2.1B | ||
| Q1 24 | $2.8B | $2.0B |
| Q4 25 | $5.1B | $2.5B | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $4.8B | $2.6B | ||
| Q1 25 | $4.7B | $2.6B | ||
| Q4 24 | $4.7B | $2.7B | ||
| Q3 24 | $4.7B | $2.7B | ||
| Q2 24 | $4.7B | $2.7B | ||
| Q1 24 | $4.7B | $2.7B |
| Q4 25 | 0.30× | 0.13× | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 0.29× | 0.18× | ||
| Q1 25 | 0.30× | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | 0.43× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $122.1M | — |
| Free Cash FlowOCF − Capex | $99.1M | — |
| FCF MarginFCF / Revenue | 21.5% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 1.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $122.1M | — | ||
| Q3 25 | $88.4M | — | ||
| Q2 25 | $120.0M | $98.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | $84.0M | $84.3M | ||
| Q3 24 | — | $63.9M | ||
| Q2 24 | $97.4M | $75.5M | ||
| Q1 24 | — | $81.0M |
| Q4 25 | $99.1M | — | ||
| Q3 25 | $71.7M | — | ||
| Q2 25 | $104.3M | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | $73.6M | $77.5M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | $88.4M | $57.5M | ||
| Q1 24 | — | $64.5M |
| Q4 25 | 21.5% | — | ||
| Q3 25 | 15.7% | — | ||
| Q2 25 | 23.9% | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | 18.7% | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | 21.8% | 18.8% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.6% | 1.5% | ||
| Q1 25 | 3.2% | 3.2% | ||
| Q4 24 | 2.6% | 2.3% | ||
| Q3 24 | 4.1% | 3.2% | ||
| Q2 24 | 2.2% | 5.9% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | 1.81× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.75× | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | 1.45× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 1.59× | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
